Clinical Trials Directory

Trials / Completed

CompletedNCT03450499

Analgesia Effects of Intravenous Ketamine After Spinal Anesthesia for Non-elective Cesarean Section

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
80 (actual)
Sponsor
B.P. Koirala Institute of Health Sciences · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

This randomized double blind study will be conducted in pregnant woman planned for non elective cesarean section under spinal anesthesia. Ketamine group will receive intravenous 0.25 mg/kg and placebo group will receive same amount of normal saline after spinal anesthesia prior to skin incision. Postoperative outcomes measures are total opioid consumption and pain scores for 24 hrs.

Conditions

Interventions

TypeNameDescription
DRUGKetaminethe analgesic affects of ketamine will be compared between the experimental and placebo group.
DRUGPlacebothe analgesic requirement will be calculated in placebo group.

Timeline

Start date
2018-04-01
Primary completion
2019-03-07
Completion
2019-03-07
First posted
2018-03-01
Last updated
2019-08-20

Locations

1 site across 1 country: Nepal

Source: ClinicalTrials.gov record NCT03450499. Inclusion in this directory is not an endorsement.

Analgesia Effects of Intravenous Ketamine After Spinal Anesthesia for Non-elective Cesarean Section (NCT03450499) · Clinical Trials Directory